Pipeline Overview

STAGE :
1
Lead Optimization
2
Pre-IND
3
Clinical Phase I
TI-168
FVIIITCR-Treg
Hemophilia A
TI-235
TCR-Treg
Multiple Sclerosis
TI-385
BAR-Tcell
B cell lymphoma
TI-495
TCR-Treg
Xeno-transplantation
TI-520
Atopic dermatitis
Copyright © 2020 TeraImmune Inc.
704 Quince Orchard Rd. STE 160 Gaithersburg, MD 20878
Phone : 301-232-4105